Tesamorelin/CJC/Ipamorelin

Description

Tesamorelin/CJC/Ipamorelin (2:1:1)
Triple Signal. Max GH Pulse. Metabolic Precision Meets Recovery Power.

This 2:1:1 blend of Tesamorelin, CJC-1295 (No DAC), and Ipamorelin combines three of the most respected GH secretagogues in peptide research—giving labs a multi-pathway model for studying natural growth hormone release, visceral fat reduction, and tissue regeneration.

Tesamorelin drives long-acting GHRH signaling with proven effects on visceral adipose tissue (VAT).
CJC-1295 (No DAC) supports shorter-lived, pulse-timed GH release for a physiological rhythm.
Ipamorelin adds ghrelin receptor activation—stimulating GH without triggering cortisol, prolactin, or hunger pathways.

Together, they create a robust tool for modeling GH axis enhancement with unmatched control and breadth.

Researchers explore this triple-stack in models involving:
⚡️ Endogenous GH and IGF-1 elevation
⚡️ Reduction of VAT and improved body composition
⚡️ Post-exertion tissue repair and anabolic signaling
⚡️ Neuroendocrine rhythm and hypothalamic-pituitary balance
This blend is ideal for research into longevity, metabolic correction, and performance recovery, offering clean synergy across all major GH pathways—without exogenous hormone interference.

Product Details:
Components: Tesamorelin / CJC-1295 (No DAC) / Ipamorelin – 2:1:1 ratio
CAS Numbers: Tesamorelin: 218949-48-5 | CJC-1295: 863288-34-0 | Ipamorelin: 170851-70-4
Form: Lyophilized peptide blend (Receptor Grade)
Storage: Store in a cool, dry place. Refrigerate or freeze for long-term use. Avoid repeated freeze-thaw cycles.

⚠️ Research Use Only
This peptide blend is sold strictly for laboratory research use only. This product is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are a qualified researcher or lab professional operating under all applicable regulations.